The t(2;5)-;associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders
dc.contributor.author | Su, Lyndon D. | en_US |
dc.contributor.author | Schnitzer, Bertram | en_US |
dc.contributor.author | Ross, Charles W. | en_US |
dc.contributor.author | Vasef, Mohammad | en_US |
dc.contributor.author | Mori, Shigeo | en_US |
dc.contributor.author | Shiota, Mami | en_US |
dc.contributor.author | Mason, David Y. | en_US |
dc.contributor.author | Pulford, Karen | en_US |
dc.contributor.author | Headington, John T. | en_US |
dc.contributor.author | Singleton, Timothy P. | en_US |
dc.date.accessioned | 2010-06-01T21:08:26Z | |
dc.date.available | 2010-06-01T21:08:26Z | |
dc.date.issued | 1997-11 | en_US |
dc.identifier.citation | Su, Lyndon D.; Schnitzer, Bertram; Ross, Charles W.; Vasef, Mohammad; Mori, Shigeo; Shiota, Mami; Mason, David Y.; Pulford, Karen; Headington, John T.; Singleton, Timothy P. (1997). "The t(2;5)-;associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders." Journal of Cutaneous Pathology 24(10): 597-603. <http://hdl.handle.net/2027.42/74223> | en_US |
dc.identifier.issn | 0303-6987 | en_US |
dc.identifier.issn | 1600-0560 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74223 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9449486&dopt=citation | en_US |
dc.format.extent | 9902488 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1997 Munksgaard | en_US |
dc.title | The t(2;5)-;associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Dermatology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationother | City of Hope National Medical Center, Duarte, California | en_US |
dc.contributor.affiliationother | University of Tokyo, Tokyo, Japan | en_US |
dc.contributor.affiliationother | John Radcliffe Hospital, Oxford, UK | en_US |
dc.identifier.pmid | 9449486 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74223/1/j.1600-0560.1997.tb01090.x.pdf | |
dc.identifier.doi | 10.1111/j.1600-0560.1997.tb01090.x | en_US |
dc.identifier.source | Journal of Cutaneous Pathology | en_US |
dc.identifier.citedreference | Morris S, Kirstein M, Valentine M, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994: 203: 1281. | en_US |
dc.identifier.citedreference | Herbst H, Anagnostopoulos J, Heinze B, Durkop H, Hummel M, Stein H. ALK gene products in anaplaslic large cell lymphomas and Hodgkin's disease. Blood 1995: 86: 1694. | en_US |
dc.identifier.citedreference | Wood G, Hardman D, Boni R, et al. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood 1996: 88: 1765. | en_US |
dc.identifier.citedreference | Fujimoto J, Shiota M, Iwahara T, et al. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc Natl Acad Sci 1996: 93: 4181. | en_US |
dc.identifier.citedreference | Shiota M, Nakamura S, Ichinohasama R, et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80 NPM/ALK: A distinct clinicopathologic entity. Blood 1995: 86: 1954. | en_US |
dc.identifier.citedreference | Shiota M, Fujimoto J, Takenaga M, et al. Diagnosis of t(2;5) (p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 1994: 84: 3648. | en_US |
dc.identifier.citedreference | DeCoteau J, Butmare J, Kinney M, Kadin M. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996: 87: 3437. | en_US |
dc.identifier.citedreference | Beylot-Barry M, Lamant L, Vergier B, et al. Detection of t(2;5) (p23;q35) translocation by reverse transcriptase polymerase chain reaction and in-situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol 1996: 149: 483. | en_US |
dc.identifier.citedreference | Lamant L, Meggetto F, Saati T, et al. High incidence of the t(2;5) (p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and p80 immunostaining. Blood 1996: 87: 284. | en_US |
dc.identifier.citedreference | Pulford K, Lamant L, Morris S, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK-1. Blood 1997: 89: 1394. | en_US |
dc.identifier.citedreference | Delsol G, Lamant L, Mariame B, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood 1997: 89: 1483. | en_US |
dc.identifier.citedreference | Bruin P, Beljaards R, Heerde P, et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 1993: 23: 127. | en_US |
dc.identifier.citedreference | Beljaards R, Kaudewitz P, Berti E, et al. Primary cutaneous CD30-posilive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. Cancer 1993: 71: 2097. | en_US |
dc.identifier.citedreference | Lopategui J, Sun L, Chan J, et al. Low frequency association of the t(2;5) (p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. Am J Pathol 1995: 146: 323. | en_US |
dc.identifier.citedreference | Sarris A, Luthra R, Papadimitracopoulou V, et al. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Blood 1996: 88: 1771. | en_US |
dc.identifier.citedreference | Wellman A, Otsuki T, Vogelbruch M, Clark H, Jaffe E, Raffeld M. Analysis of the t(2;5) (p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in oilier non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 1995: 86: 2321. | en_US |
dc.identifier.citedreference | Willemze R, Beljaards R. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders – a proposal for classification and guidelines for management and treatment. Am Acad Dermatol 1993: 28: 973. | en_US |
dc.identifier.citedreference | Stein H, Dallenbach F. Diffuse large cell lymphomas of B and T cell type. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore: Williams & Wilkins, 1992: 698. | en_US |
dc.identifier.citedreference | Paulli M, Emilio B, Rosso R, et al. CD30/Ki-1-positive lymphoproliferative disorders of the skin – clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol 1995: 13: 1343. | en_US |
dc.identifier.citedreference | Shi SR, Key ME, Kalra K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991: 39: 741. | en_US |
dc.identifier.citedreference | DeCoteau J, Kinney M, Kadin M. Presence of t(2;5) in primary CD30+ cutaneous lymphoproliferative disorders. Blood 1996: 88: 3240. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.